

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | exogenous drug catabolic process (GO:0042738) | 8.24305068 |
| 2 | omega-hydroxylase P450 pathway (GO:0097267) | 8.01290872 |
| 3 | epoxygenase P450 pathway (GO:0019373) | 7.94450051 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.69239759 |
| 5 | L-phenylalanine catabolic process (GO:0006559) | 7.69239759 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.34870966 |
| 7 | L-phenylalanine metabolic process (GO:0006558) | 7.34870966 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 6.91615472 |
| 9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.33929608 |
| 10 | indole-containing compound catabolic process (GO:0042436) | 6.24530422 |
| 11 | indolalkylamine catabolic process (GO:0046218) | 6.24530422 |
| 12 | tryptophan catabolic process (GO:0006569) | 6.24530422 |
| 13 | kynurenine metabolic process (GO:0070189) | 6.09935017 |
| 14 | bile acid biosynthetic process (GO:0006699) | 6.02061945 |
| 15 | tryptophan metabolic process (GO:0006568) | 5.87470659 |
| 16 | glyoxylate metabolic process (GO:0046487) | 5.84479980 |
| 17 | urea cycle (GO:0000050) | 5.82300275 |
| 18 | urea metabolic process (GO:0019627) | 5.82300275 |
| 19 | negative regulation of fibrinolysis (GO:0051918) | 5.64263788 |
| 20 | high-density lipoprotein particle remodeling (GO:0034375) | 5.59763742 |
| 21 | alpha-linolenic acid metabolic process (GO:0036109) | 5.56232258 |
| 22 | drug metabolic process (GO:0017144) | 5.49585641 |
| 23 | oxidative demethylation (GO:0070989) | 5.49238789 |
| 24 | cysteine metabolic process (GO:0006534) | 5.49172434 |
| 25 | sulfur amino acid catabolic process (GO:0000098) | 5.47714657 |
| 26 | regulation of fibrinolysis (GO:0051917) | 5.45479546 |
| 27 | protein carboxylation (GO:0018214) | 5.39348362 |
| 28 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.39348362 |
| 29 | complement activation, alternative pathway (GO:0006957) | 5.37309671 |
| 30 | nitrogen cycle metabolic process (GO:0071941) | 5.35307596 |
| 31 | regulation of protein activation cascade (GO:2000257) | 5.34867740 |
| 32 | intestinal cholesterol absorption (GO:0030299) | 5.26080797 |
| 33 | serine family amino acid catabolic process (GO:0009071) | 5.22765352 |
| 34 | bile acid metabolic process (GO:0008206) | 5.12888313 |
| 35 | opsonization (GO:0008228) | 5.04681731 |
| 36 | aromatic amino acid family metabolic process (GO:0009072) | 5.02616082 |
| 37 | regulation of complement activation (GO:0030449) | 4.99186823 |
| 38 | regulation of plasminogen activation (GO:0010755) | 4.96422096 |
| 39 | ethanol metabolic process (GO:0006067) | 4.95406458 |
| 40 | homocysteine metabolic process (GO:0050667) | 4.94666475 |
| 41 | acute-phase response (GO:0006953) | 4.91868234 |
| 42 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.90605181 |
| 43 | tyrosine metabolic process (GO:0006570) | 4.89574965 |
| 44 | regulation of cholesterol esterification (GO:0010872) | 4.87688993 |
| 45 | regulation of humoral immune response (GO:0002920) | 4.87197426 |
| 46 | reverse cholesterol transport (GO:0043691) | 4.87065450 |
| 47 | regulation of triglyceride catabolic process (GO:0010896) | 4.83790455 |
| 48 | protein-lipid complex remodeling (GO:0034368) | 4.79841603 |
| 49 | macromolecular complex remodeling (GO:0034367) | 4.79841603 |
| 50 | plasma lipoprotein particle remodeling (GO:0034369) | 4.79841603 |
| 51 | * alpha-amino acid catabolic process (GO:1901606) | 4.65923043 |
| 52 | amino-acid betaine metabolic process (GO:0006577) | 4.63397242 |
| 53 | acylglycerol homeostasis (GO:0055090) | 4.62707573 |
| 54 | triglyceride homeostasis (GO:0070328) | 4.62707573 |
| 55 | lysine metabolic process (GO:0006553) | 4.59855239 |
| 56 | lysine catabolic process (GO:0006554) | 4.59855239 |
| 57 | negative regulation of protein activation cascade (GO:2000258) | 4.59256782 |
| 58 | negative regulation of cholesterol transport (GO:0032375) | 4.58742471 |
| 59 | negative regulation of sterol transport (GO:0032372) | 4.58742471 |
| 60 | phospholipid efflux (GO:0033700) | 4.56759337 |
| 61 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.54293953 |
| 62 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.54293953 |
| 63 | negative regulation of hemostasis (GO:1900047) | 4.50687199 |
| 64 | negative regulation of blood coagulation (GO:0030195) | 4.50687199 |
| 65 | glycine metabolic process (GO:0006544) | 4.49021396 |
| 66 | coenzyme catabolic process (GO:0009109) | 4.45420293 |
| 67 | bile acid and bile salt transport (GO:0015721) | 4.43629780 |
| 68 | cellular ketone body metabolic process (GO:0046950) | 4.43308515 |
| 69 | indolalkylamine metabolic process (GO:0006586) | 4.42404567 |
| 70 | plasma lipoprotein particle clearance (GO:0034381) | 4.40405882 |
| 71 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.40191896 |
| 72 | phenylpropanoid metabolic process (GO:0009698) | 4.35645640 |
| 73 | cellular biogenic amine catabolic process (GO:0042402) | 4.33851902 |
| 74 | amine catabolic process (GO:0009310) | 4.33851902 |
| 75 | * cellular amino acid catabolic process (GO:0009063) | 4.28596308 |
| 76 | serine family amino acid metabolic process (GO:0009069) | 4.25094654 |
| 77 | cellular glucuronidation (GO:0052695) | 4.25012430 |
| 78 | cholesterol efflux (GO:0033344) | 4.24466255 |
| 79 | S-adenosylmethionine metabolic process (GO:0046500) | 4.15870605 |
| 80 | benzene-containing compound metabolic process (GO:0042537) | 4.14647685 |
| 81 | cellular modified amino acid catabolic process (GO:0042219) | 4.12891656 |
| 82 | ethanol oxidation (GO:0006069) | 4.11506954 |
| 83 | serine family amino acid biosynthetic process (GO:0009070) | 4.11265073 |
| 84 | arginine metabolic process (GO:0006525) | 4.11051983 |
| 85 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.08895585 |
| 86 | aldehyde catabolic process (GO:0046185) | 4.07905684 |
| 87 | low-density lipoprotein particle remodeling (GO:0034374) | 4.07459423 |
| 88 | * glutamate metabolic process (GO:0006536) | 4.05273683 |
| 89 | fibrinolysis (GO:0042730) | 4.03295296 |
| 90 | negative regulation of coagulation (GO:0050819) | 4.02870311 |
| 91 | plasma lipoprotein particle assembly (GO:0034377) | 4.02470246 |
| 92 | negative regulation of wound healing (GO:0061045) | 3.96191398 |
| 93 | positive regulation of blood coagulation (GO:0030194) | 3.91671032 |
| 94 | positive regulation of hemostasis (GO:1900048) | 3.91671032 |
| 95 | blood coagulation, intrinsic pathway (GO:0007597) | 3.87526271 |
| 96 | * imidazole-containing compound metabolic process (GO:0052803) | 3.86117052 |
| 97 | ketone body metabolic process (GO:1902224) | 3.84575404 |
| 98 | cofactor catabolic process (GO:0051187) | 3.83791401 |
| 99 | drug catabolic process (GO:0042737) | 3.83389909 |
| 100 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.82226808 |
| 101 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.78198295 |
| 102 | complement activation, classical pathway (GO:0006958) | 3.77193469 |
| 103 | uronic acid metabolic process (GO:0006063) | 3.76920439 |
| 104 | glucuronate metabolic process (GO:0019585) | 3.76920439 |
| 105 | flavonoid metabolic process (GO:0009812) | 3.76741983 |
| 106 | alkaloid metabolic process (GO:0009820) | 3.75871516 |
| 107 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.75141402 |
| 108 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.75141402 |
| 109 | regulation of bile acid biosynthetic process (GO:0070857) | 3.74523001 |
| 110 | cholesterol homeostasis (GO:0042632) | 3.74382970 |
| 111 | complement activation (GO:0006956) | 3.74085525 |
| 112 | * organic acid catabolic process (GO:0016054) | 3.73890360 |
| 113 | * carboxylic acid catabolic process (GO:0046395) | 3.73890360 |
| 114 | regulation of apoptotic cell clearance (GO:2000425) | 3.73525791 |
| 115 | protein activation cascade (GO:0072376) | 3.73130163 |
| 116 | negative regulation of lipase activity (GO:0060192) | 3.73061184 |
| 117 | phospholipid homeostasis (GO:0055091) | 3.71926142 |
| 118 | positive regulation of lipid catabolic process (GO:0050996) | 3.71720701 |
| 119 | acetyl-CoA metabolic process (GO:0006084) | 3.69222126 |
| 120 | sterol homeostasis (GO:0055092) | 3.67970191 |
| 121 | cytolysis (GO:0019835) | 3.67609935 |
| 122 | regulation of cholesterol homeostasis (GO:2000188) | 3.64758622 |
| 123 | negative regulation of complement activation (GO:0045916) | 3.64347620 |
| 124 | short-chain fatty acid metabolic process (GO:0046459) | 3.64226989 |
| 125 | plasma lipoprotein particle organization (GO:0071827) | 3.64204028 |
| 126 | acute inflammatory response (GO:0002526) | 3.63946121 |
| 127 | NAD biosynthetic process (GO:0009435) | 3.61343677 |
| 128 | protein-lipid complex assembly (GO:0065005) | 3.60502624 |
| 129 | positive regulation of coagulation (GO:0050820) | 3.57395834 |
| 130 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.56136201 |
| 131 | protein-lipid complex subunit organization (GO:0071825) | 3.51046660 |
| 132 | response to mercury ion (GO:0046689) | 3.37485196 |
| 133 | sodium-independent organic anion transport (GO:0043252) | 3.33611217 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.41853746 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.21083662 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.07631529 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.51182994 |
| 5 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.23057534 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.13637594 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.78073419 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.04328027 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.01974787 |
| 10 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.09162850 |
| 11 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.08124770 |
| 12 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 12.0497707 |
| 13 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.98617467 |
| 14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.94421591 |
| 15 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.68719468 |
| 16 | P68_20966046_ChIP-Seq_HELA_Human | 1.66430848 |
| 17 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.61846845 |
| 18 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.58960825 |
| 19 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.57680479 |
| 20 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.57348643 |
| 21 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.53702619 |
| 22 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.51786106 |
| 23 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.49682424 |
| 24 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.49620076 |
| 25 | GATA1_22025678_ChIP-Seq_K562_Human | 1.45053223 |
| 26 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.44818497 |
| 27 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.40046865 |
| 28 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.39788301 |
| 29 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29220222 |
| 30 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.28416827 |
| 31 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.28135529 |
| 32 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.23044387 |
| 33 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.21122213 |
| 34 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.20609900 |
| 35 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.19888370 |
| 36 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.19110605 |
| 37 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.18507309 |
| 38 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.17618305 |
| 39 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.17267678 |
| 40 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.15566025 |
| 41 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.15147909 |
| 42 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.10820718 |
| 43 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.09972047 |
| 44 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.09594212 |
| 45 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.09533467 |
| 46 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.09380299 |
| 47 | MYC_22102868_ChIP-Seq_BL_Human | 1.08095343 |
| 48 | SA1_27219007_Chip-Seq_Bcells_Human | 1.06653836 |
| 49 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.06482194 |
| 50 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.04775523 |
| 51 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.04431229 |
| 52 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.03995729 |
| 53 | P300_27268052_Chip-Seq_Bcells_Human | 1.03767819 |
| 54 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.03056649 |
| 55 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.02585061 |
| 56 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.02443934 |
| 57 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.00539498 |
| 58 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.00380466 |
| 59 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96912633 |
| 60 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.96263723 |
| 61 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.96044413 |
| 62 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.94910878 |
| 63 | ERA_21632823_ChIP-Seq_H3396_Human | 0.94700161 |
| 64 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.93889517 |
| 65 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.93716541 |
| 66 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91202968 |
| 67 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.90947939 |
| 68 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.90130499 |
| 69 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.89773476 |
| 70 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.86798088 |
| 71 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.86664847 |
| 72 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.86645484 |
| 73 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.86575108 |
| 74 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.85714449 |
| 75 | MAF_26560356_Chip-Seq_TH1_Human | 0.85576400 |
| 76 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.85568169 |
| 77 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.85135003 |
| 78 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.84464332 |
| 79 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.84237350 |
| 80 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.84198478 |
| 81 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.83454519 |
| 82 | MAF_26560356_Chip-Seq_TH2_Human | 0.83184910 |
| 83 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.82998598 |
| 84 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.82069648 |
| 85 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.81969418 |
| 86 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.80310586 |
| 87 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.79632232 |
| 88 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.78956451 |
| 89 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.78669832 |
| 90 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.78521482 |
| 91 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.78220827 |
| 92 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.77877097 |
| 93 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 0.77313092 |
| 94 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.77048557 |
| 95 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.76287970 |
| 96 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.75847635 |
| 97 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.75447224 |
| 98 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.75200107 |
| 99 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.74248482 |
| 100 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.74143189 |
| 101 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.71716491 |
| 102 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.70231601 |
| 103 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.66061478 |
| 104 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.65750560 |
| 105 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.64550886 |
| 106 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.64264775 |
| 107 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.64200280 |
| 108 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.63979223 |
| 109 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.63979223 |
| 110 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.62827254 |
| 111 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.61505807 |
| 112 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.60016336 |
| 113 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.59973893 |
| 114 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.56920152 |
| 115 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.56051489 |
| 116 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.55800369 |
| 117 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.53566756 |
| 118 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.53084311 |
| 119 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.52083167 |
| 120 | AR_20517297_ChIP-Seq_VCAP_Human | 0.51979474 |
| 121 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.51861048 |
| 122 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.51817271 |
| 123 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.51566725 |
| 124 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.50935888 |
| 125 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.48995012 |
| 126 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.48414870 |
| 127 | CBP_21632823_ChIP-Seq_H3396_Human | 0.47416837 |
| 128 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.47212430 |
| 129 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.46391818 |
| 130 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.45170821 |
| 131 | * STAT1_17558387_ChIP-Seq_HELA_Human | 0.44831439 |
| 132 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.44009182 |
| 133 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.43698368 |
| 134 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.42786970 |
| 135 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.42545523 |
| 136 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.42526065 |
| 137 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.42451652 |
| 138 | GATA1_19941826_ChIP-Seq_K562_Human | 0.42238616 |
| 139 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.42206913 |
| 140 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.41811577 |
| 141 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.41774767 |
| 142 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.41507239 |
| 143 | GATA2_19941826_ChIP-Seq_K562_Human | 0.39455051 |
| 144 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.39272207 |
| 145 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.39227593 |
| 146 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.39063737 |
| 147 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.38506932 |
| 148 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.38201943 |
| 149 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.38025355 |
| 150 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.37875650 |
| 151 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.37444130 |
| 152 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.36033608 |
| 153 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.35576478 |
| 154 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.34204824 |
| 155 | NCOR_22424771_ChIP-Seq_293T_Human | 0.33907481 |
| 156 | * LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.33453365 |
| 157 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.32603590 |
| 158 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.32244744 |
| 159 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.32086514 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.29475894 |
| 2 | MP0005360_urolithiasis | 7.60580059 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.48186452 |
| 4 | MP0005365_abnormal_bile_salt | 6.18870648 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.09562084 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.30473271 |
| 7 | MP0003252_abnormal_bile_duct | 3.94010845 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.59010195 |
| 9 | MP0009840_abnormal_foam_cell | 3.27439703 |
| 10 | MP0005083_abnormal_biliary_tract | 3.04309534 |
| 11 | MP0003195_calcinosis | 2.90273520 |
| 12 | MP0005332_abnormal_amino_acid | 2.77865176 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.58923293 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.28013484 |
| 15 | MP0000609_abnormal_liver_physiology | 2.16125627 |
| 16 | MP0004019_abnormal_vitamin_homeostasis | 2.11160067 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 2.09693435 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 1.99686300 |
| 19 | MP0003868_abnormal_feces_composition | 1.93329995 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.82832341 |
| 21 | MP0001764_abnormal_homeostasis | 1.70238403 |
| 22 | MP0009697_abnormal_copulation | 1.62092335 |
| 23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.56788082 |
| 24 | MP0005451_abnormal_body_composition | 1.45913350 |
| 25 | MP0003011_delayed_dark_adaptation | 1.37768784 |
| 26 | MP0005058_abnormal_lysosome_morphology | 1.33521087 |
| 27 | MP0003186_abnormal_redox_activity | 1.28105028 |
| 28 | MP0003656_abnormal_erythrocyte_physiolo | 1.26072115 |
| 29 | MP0009643_abnormal_urine_homeostasis | 1.21922055 |
| 30 | MP0000598_abnormal_liver_morphology | 1.17912643 |
| 31 | MP0003705_abnormal_hypodermis_morpholog | 1.17624299 |
| 32 | MP0005647_abnormal_sex_gland | 1.14125183 |
| 33 | MP0002254_reproductive_system_inflammat | 1.09312980 |
| 34 | MP0000604_amyloidosis | 1.07737175 |
| 35 | MP0009764_decreased_sensitivity_to | 1.04626950 |
| 36 | MP0009763_increased_sensitivity_to | 1.01778150 |
| 37 | MP0010368_abnormal_lymphatic_system | 0.94650592 |
| 38 | MP0005636_abnormal_mineral_homeostasis | 0.90406037 |
| 39 | MP0008469_abnormal_protein_level | 0.89005589 |
| 40 | MP0005410_abnormal_fertilization | 0.88586452 |
| 41 | MP0009642_abnormal_blood_homeostasis | 0.86776850 |
| 42 | MP0005408_hypopigmentation | 0.86465699 |
| 43 | MP0006036_abnormal_mitochondrial_physio | 0.81431046 |
| 44 | MP0005376_homeostasis/metabolism_phenot | 0.81245624 |
| 45 | MP0001915_intracranial_hemorrhage | 0.80427499 |
| 46 | MP0005377_hearing/vestibular/ear_phenot | 0.79755548 |
| 47 | MP0003878_abnormal_ear_physiology | 0.79755548 |
| 48 | MP0002876_abnormal_thyroid_physiology | 0.79736016 |
| 49 | MP0003172_abnormal_lysosome_physiology | 0.78884785 |
| 50 | MP0009785_altered_susceptibility_to | 0.78264560 |
| 51 | MP0009765_abnormal_xenobiotic_induced | 0.77900376 |
| 52 | MP0003879_abnormal_hair_cell | 0.77549316 |
| 53 | MP0002078_abnormal_glucose_homeostasis | 0.76975449 |
| 54 | MP0005670_abnormal_white_adipose | 0.75920700 |
| 55 | MP0005084_abnormal_gallbladder_morpholo | 0.75239094 |
| 56 | MP0002249_abnormal_larynx_morphology | 0.72895708 |
| 57 | MP0002971_abnormal_brown_adipose | 0.71836578 |
| 58 | MP0005220_abnormal_exocrine_pancreas | 0.71205844 |
| 59 | MP0001545_abnormal_hematopoietic_system | 0.69313156 |
| 60 | MP0005397_hematopoietic_system_phenotyp | 0.69313156 |
| 61 | MP0005334_abnormal_fat_pad | 0.68695345 |
| 62 | MP0004130_abnormal_muscle_cell | 0.67701412 |
| 63 | MP0001661_extended_life_span | 0.66866813 |
| 64 | MP0005535_abnormal_body_temperature | 0.66798112 |
| 65 | MP0003690_abnormal_glial_cell | 0.66535892 |
| 66 | MP0005266_abnormal_metabolism | 0.66012554 |
| 67 | MP0009053_abnormal_anal_canal | 0.64771211 |
| 68 | MP0002282_abnormal_trachea_morphology | 0.62861819 |
| 69 | MP0003329_amyloid_beta_deposits | 0.62582044 |
| 70 | MP0009333_abnormal_splenocyte_physiolog | 0.62553155 |
| 71 | MP0000639_abnormal_adrenal_gland | 0.61443979 |
| 72 | MP0002089_abnormal_postnatal_growth/wei | 0.60776115 |
| 73 | MP0002419_abnormal_innate_immunity | 0.58355772 |
| 74 | MP0003303_peritoneal_inflammation | 0.58298283 |
| 75 | MP0005025_abnormal_response_to | 0.57573799 |
| 76 | MP0001756_abnormal_urination | 0.57350124 |
| 77 | MP0001986_abnormal_taste_sensitivity | 0.57347889 |
| 78 | MP0000685_abnormal_immune_system | 0.57122543 |
| 79 | MP0006035_abnormal_mitochondrial_morpho | 0.56928280 |
| 80 | MP0005023_abnormal_wound_healing | 0.56724023 |
| 81 | MP0005448_abnormal_energy_balance | 0.54808027 |
| 82 | MP0005464_abnormal_platelet_physiology | 0.53884023 |
| 83 | MP0002933_joint_inflammation | 0.51713238 |
| 84 | MP0002822_catalepsy | 0.51120755 |
| 85 | MP0002332_abnormal_exercise_endurance | 0.49772163 |
| 86 | MP0000678_abnormal_parathyroid_gland | 0.48073105 |
| 87 | MP0005395_other_phenotype | 0.48070690 |
| 88 | MP0003638_abnormal_response/metabolism_ | 0.46819878 |
| 89 | MP0008874_decreased_physiological_sensi | 0.45420654 |
| 90 | MP0003718_maternal_effect | 0.45371094 |
| 91 | MP0000566_synostosis | 0.45364558 |
| 92 | MP0002928_abnormal_bile_duct | 0.45237500 |
| 93 | MP0008873_increased_physiological_sensi | 0.44327992 |
| 94 | MP0002136_abnormal_kidney_physiology | 0.43991469 |
| 95 | MP0003724_increased_susceptibility_to | 0.43723540 |
| 96 | MP0004381_abnormal_hair_follicle | 0.43667804 |
| 97 | MP0003436_decreased_susceptibility_to | 0.43453399 |
| 98 | MP0005409_darkened_coat_color | 0.43158557 |
| 99 | MP0004782_abnormal_surfactant_physiolog | 0.41274207 |
| 100 | MP0003075_altered_response_to | 0.40820475 |
| 101 | MP0002837_dystrophic_cardiac_calcinosis | 0.40286432 |
| 102 | MP0003953_abnormal_hormone_level | 0.39839638 |
| 103 | MP0005076_abnormal_cell_differentiation | 0.39591880 |
| 104 | MP0005248_abnormal_Harderian_gland | 0.39207285 |
| 105 | MP0010155_abnormal_intestine_physiology | 0.39048280 |
| 106 | MP0005375_adipose_tissue_phenotype | 0.38916397 |
| 107 | MP0008260_abnormal_autophagy | 0.38431023 |
| 108 | MP0005166_decreased_susceptibility_to | 0.37843757 |
| 109 | MP0008872_abnormal_physiological_respon | 0.36949424 |
| 110 | MP0009672_abnormal_birth_weight | 0.36433211 |
| 111 | MP0000858_altered_metastatic_potential | 0.36419733 |
| 112 | MP0001851_eye_inflammation | 0.34741808 |
| 113 | MP0005666_abnormal_adipose_tissue | 0.34469327 |
| 114 | MP0000579_abnormal_nail_morphology | 0.34305625 |
| 115 | MP0006082_CNS_inflammation | 0.33682396 |
| 116 | MP0002796_impaired_skin_barrier | 0.32807868 |
| 117 | MP0000249_abnormal_blood_vessel | 0.32422412 |
| 118 | MP0004883_abnormal_blood_vessel | 0.32390909 |
| 119 | MP0000230_abnormal_systemic_arterial | 0.31985466 |
| 120 | MP0001853_heart_inflammation | 0.31962515 |
| 121 | MP0001243_abnormal_dermal_layer | 0.31955053 |
| 122 | MP0009115_abnormal_fat_cell | 0.31884230 |
| 123 | MP0009384_cardiac_valve_regurgitation | 0.31767812 |
| 124 | MP0002168_other_aberrant_phenotype | 0.30809913 |
| 125 | MP0002970_abnormal_white_adipose | 0.30035794 |
| 126 | MP0001845_abnormal_inflammatory_respons | 0.28514095 |
| 127 | MP0001881_abnormal_mammary_gland | 0.27501981 |
| 128 | MP0002132_abnormal_respiratory_system | 0.25290068 |
| 129 | MP0005164_abnormal_response_to | 0.25279005 |
| 130 | MP0002060_abnormal_skin_morphology | 0.23620966 |
| 131 | MP0002090_abnormal_vision | 0.22353669 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.50643201 |
| 2 | Deep venous thrombosis (HP:0002625) | 7.45415735 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 7.39448905 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.78720185 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.61728062 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.46188481 |
| 7 | Xanthomatosis (HP:0000991) | 6.31626095 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.61234902 |
| 9 | Complement deficiency (HP:0004431) | 5.36043523 |
| 10 | Joint hemorrhage (HP:0005261) | 4.84143721 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.81130206 |
| 12 | Hyperammonemia (HP:0001987) | 4.62505196 |
| 13 | Epidermoid cyst (HP:0200040) | 4.57981700 |
| 14 | Abnormality of the common coagulation pathway (HP:0010990) | 4.45824695 |
| 15 | Hyperglycinemia (HP:0002154) | 4.42682228 |
| 16 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.40388500 |
| 17 | Abnormality of methionine metabolism (HP:0010901) | 4.37996303 |
| 18 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.32805208 |
| 19 | Ketosis (HP:0001946) | 4.23493121 |
| 20 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.19879626 |
| 21 | Hypoalphalipoproteinemia (HP:0003233) | 4.19281232 |
| 22 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.18609183 |
| 23 | Fat malabsorption (HP:0002630) | 4.15047749 |
| 24 | Hyperglycinuria (HP:0003108) | 3.92527532 |
| 25 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.91866649 |
| 26 | Abnormality of complement system (HP:0005339) | 3.90995223 |
| 27 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.90766352 |
| 28 | Abnormality of glycine metabolism (HP:0010895) | 3.90766352 |
| 29 | Hypoglycemic coma (HP:0001325) | 3.78947581 |
| 30 | Abnormality of the intrinsic pathway (HP:0010989) | 3.77494105 |
| 31 | Conjugated hyperbilirubinemia (HP:0002908) | 3.77443833 |
| 32 | Hypercholesterolemia (HP:0003124) | 3.64816270 |
| 33 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.39053120 |
| 34 | Hyperbilirubinemia (HP:0002904) | 3.36098455 |
| 35 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.32792360 |
| 36 | Steatorrhea (HP:0002570) | 3.11747471 |
| 37 | Delayed CNS myelination (HP:0002188) | 3.09966567 |
| 38 | Abnormality of serum amino acid levels (HP:0003112) | 3.09354361 |
| 39 | Abnormality of nucleobase metabolism (HP:0010932) | 3.06468501 |
| 40 | Purpura (HP:0000979) | 3.03235785 |
| 41 | Spontaneous abortion (HP:0005268) | 3.02574438 |
| 42 | Hepatocellular carcinoma (HP:0001402) | 3.00569482 |
| 43 | Myocardial infarction (HP:0001658) | 2.99223976 |
| 44 | Hypochromic microcytic anemia (HP:0004840) | 2.97435009 |
| 45 | Ketoacidosis (HP:0001993) | 2.96174322 |
| 46 | Skin nodule (HP:0200036) | 2.82838651 |
| 47 | Metabolic acidosis (HP:0001942) | 2.75110364 |
| 48 | Systemic lupus erythematosus (HP:0002725) | 2.74392630 |
| 49 | Abnormality of purine metabolism (HP:0004352) | 2.63769428 |
| 50 | Lethargy (HP:0001254) | 2.60265310 |
| 51 | Acanthocytosis (HP:0001927) | 2.59836601 |
| 52 | Vascular calcification (HP:0004934) | 2.57453946 |
| 53 | Increased serum ferritin (HP:0003281) | 2.55331890 |
| 54 | Dicarboxylic aciduria (HP:0003215) | 2.54844335 |
| 55 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.54844335 |
| 56 | Abnormal gallbladder morphology (HP:0012437) | 2.49374060 |
| 57 | Spastic diplegia (HP:0001264) | 2.46934668 |
| 58 | Mitral stenosis (HP:0001718) | 2.46463343 |
| 59 | Cerebral edema (HP:0002181) | 2.45472760 |
| 60 | Glomerulonephritis (HP:0000099) | 2.43223704 |
| 61 | Cholelithiasis (HP:0001081) | 2.42440726 |
| 62 | Epistaxis (HP:0000421) | 2.42020217 |
| 63 | Gout (HP:0001997) | 2.41356170 |
| 64 | Hypoglycemic seizures (HP:0002173) | 2.40936035 |
| 65 | Neonatal onset (HP:0003623) | 2.38089497 |
| 66 | Irritability (HP:0000737) | 2.36483700 |
| 67 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.34967973 |
| 68 | Amyloidosis (HP:0011034) | 2.34231725 |
| 69 | Cholecystitis (HP:0001082) | 2.31593412 |
| 70 | Abnormal gallbladder physiology (HP:0012438) | 2.31593412 |
| 71 | Cardiovascular calcification (HP:0011915) | 2.28138439 |
| 72 | Malnutrition (HP:0004395) | 2.25842378 |
| 73 | Osteomalacia (HP:0002749) | 2.24491168 |
| 74 | Gingival bleeding (HP:0000225) | 2.22452309 |
| 75 | Neonatal hypoglycemia (HP:0001998) | 2.21138043 |
| 76 | Elevated alkaline phosphatase (HP:0003155) | 2.18570953 |
| 77 | Esophageal varix (HP:0002040) | 2.18385465 |
| 78 | Menorrhagia (HP:0000132) | 2.14973560 |
| 79 | Pancreatitis (HP:0001733) | 2.14215564 |
| 80 | Joint swelling (HP:0001386) | 2.13878884 |
| 81 | Sensorimotor neuropathy (HP:0007141) | 2.12953876 |
| 82 | Brushfield spots (HP:0001088) | 2.12825873 |
| 83 | Thrombophlebitis (HP:0004418) | 2.10925715 |
| 84 | Enlarged kidneys (HP:0000105) | 2.09556729 |
| 85 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.07607113 |
| 86 | Late onset (HP:0003584) | 2.06314700 |
| 87 | Vomiting (HP:0002013) | 2.05394173 |
| 88 | Poikilocytosis (HP:0004447) | 2.04011125 |
| 89 | Fair hair (HP:0002286) | 2.03732286 |
| 90 | Abnormality of the gallbladder (HP:0005264) | 2.02355159 |
| 91 | Hemorrhage of the eye (HP:0011885) | 2.00871555 |
| 92 | Opisthotonus (HP:0002179) | 2.00199736 |
| 93 | Abnormality of the Achilles tendon (HP:0005109) | 2.00182796 |
| 94 | Generalized aminoaciduria (HP:0002909) | 1.98650982 |
| 95 | Cerebral palsy (HP:0100021) | 1.98072962 |
| 96 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.95329028 |
| 97 | Abnormality of iron homeostasis (HP:0011031) | 1.92228127 |
| 98 | Rickets (HP:0002748) | 1.91858472 |
| 99 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.88747090 |
| 100 | Abnormal cartilage morphology (HP:0002763) | 1.87791695 |
| 101 | Renal cortical cysts (HP:0000803) | 1.86156787 |
| 102 | Hypophosphatemic rickets (HP:0004912) | 1.85741929 |
| 103 | Hydroxyprolinuria (HP:0003080) | 1.83529266 |
| 104 | Abnormality of proline metabolism (HP:0010907) | 1.83529266 |
| 105 | Alkalosis (HP:0001948) | 1.83515102 |
| 106 | Elevated hepatic transaminases (HP:0002910) | 1.81700449 |
| 107 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.80811889 |
| 108 | Reduced antithrombin III activity (HP:0001976) | 1.80156952 |
| 109 | Gangrene (HP:0100758) | 1.79837065 |
| 110 | Status epilepticus (HP:0002133) | 1.77974740 |
| 111 | Hypertriglyceridemia (HP:0002155) | 1.75151515 |
| 112 | Arthropathy (HP:0003040) | 1.74725380 |
| 113 | Abnormal platelet function (HP:0011869) | 1.73514632 |
| 114 | Impaired platelet aggregation (HP:0003540) | 1.73514632 |
| 115 | Nephritis (HP:0000123) | 1.72759232 |
| 116 | Abnormality of vitamin metabolism (HP:0100508) | 1.72105868 |
| 117 | Pulmonary embolism (HP:0002204) | 1.71605403 |
| 118 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.70635013 |
| 119 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.70635013 |
| 120 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.70635013 |
| 121 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.69895685 |
| 122 | Mucopolysacchariduria (HP:0008155) | 1.69895685 |
| 123 | Increased mean platelet volume (HP:0011877) | 1.62780751 |
| 124 | Reticulocytosis (HP:0001923) | 1.60539105 |
| 125 | Abnormal platelet volume (HP:0011876) | 1.60000011 |
| 126 | Anorexia (HP:0002039) | 1.54039587 |
| 127 | Orchitis (HP:0100796) | 1.52580488 |
| 128 | Hypophosphatemia (HP:0002148) | 1.50980722 |
| 129 | Potter facies (HP:0002009) | 1.48117815 |
| 130 | Facial shape deformation (HP:0011334) | 1.48117815 |
| 131 | Prolonged bleeding time (HP:0003010) | 1.45817945 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.12739527 |
| 2 | FGFR4 | 4.73515739 |
| 3 | SIK1 | 4.61780188 |
| 4 | ERN1 | 4.22547180 |
| 5 | TAOK3 | 3.11440095 |
| 6 | INSRR | 2.99446999 |
| 7 | ERBB4 | 2.91948644 |
| 8 | CDK12 | 2.34099225 |
| 9 | MAP2K4 | 2.30358244 |
| 10 | PKN2 | 2.26023003 |
| 11 | MAP4K1 | 2.15866585 |
| 12 | MST1R | 2.15385615 |
| 13 | FLT3 | 1.99633875 |
| 14 | MAPK11 | 1.91398045 |
| 15 | AKT3 | 1.90157988 |
| 16 | PIK3CG | 1.81152933 |
| 17 | TYK2 | 1.77388183 |
| 18 | TRIB3 | 1.72851840 |
| 19 | TNK2 | 1.64708617 |
| 20 | LATS1 | 1.60673382 |
| 21 | DAPK2 | 1.55229356 |
| 22 | PTK6 | 1.51546119 |
| 23 | ABL2 | 1.47508801 |
| 24 | FGFR2 | 1.43940456 |
| 25 | NEK9 | 1.38189126 |
| 26 | BLK | 1.37875297 |
| 27 | ZAP70 | 1.36896977 |
| 28 | FRK | 1.36378080 |
| 29 | PRPF4B | 1.34251699 |
| 30 | EPHA2 | 1.31311701 |
| 31 | KDR | 1.30402204 |
| 32 | TESK2 | 1.30016652 |
| 33 | JAK2 | 1.25133077 |
| 34 | MAP3K7 | 1.22170534 |
| 35 | SIK2 | 1.19436743 |
| 36 | WNK4 | 1.19060696 |
| 37 | DDR2 | 1.13259675 |
| 38 | PINK1 | 1.12275925 |
| 39 | PRKAA2 | 1.11044922 |
| 40 | TBK1 | 1.10517509 |
| 41 | MAP3K10 | 1.09422817 |
| 42 | GRK6 | 1.08042548 |
| 43 | MAP3K14 | 1.07436578 |
| 44 | ERBB2 | 1.04676096 |
| 45 | JAK1 | 1.04139220 |
| 46 | MAP2K3 | 1.02758324 |
| 47 | MAPK4 | 0.98512337 |
| 48 | SMG1 | 0.98062337 |
| 49 | MAPK15 | 0.95006308 |
| 50 | PRKCZ | 0.92198613 |
| 51 | EPHB1 | 0.88732906 |
| 52 | MET | 0.87103957 |
| 53 | MAPKAPK3 | 0.82812684 |
| 54 | STK38L | 0.82465554 |
| 55 | MAPK12 | 0.82014814 |
| 56 | CDK6 | 0.81193912 |
| 57 | EPHA3 | 0.80904504 |
| 58 | IKBKB | 0.79807106 |
| 59 | MAP3K3 | 0.78482212 |
| 60 | CHUK | 0.78146511 |
| 61 | STK38 | 0.77583879 |
| 62 | MARK2 | 0.77321856 |
| 63 | TIE1 | 0.76968215 |
| 64 | CDC42BPA | 0.76641793 |
| 65 | EEF2K | 0.75006880 |
| 66 | PRKACG | 0.74894375 |
| 67 | MAP3K11 | 0.74303808 |
| 68 | MAP3K2 | 0.73444255 |
| 69 | DYRK1B | 0.71897291 |
| 70 | CSK | 0.71689622 |
| 71 | CAMK2G | 0.70839453 |
| 72 | MAP2K6 | 0.65363745 |
| 73 | IRAK3 | 0.64999094 |
| 74 | GSK3A | 0.64954498 |
| 75 | PRKAA1 | 0.63902091 |
| 76 | CDK7 | 0.63534753 |
| 77 | SGK3 | 0.62260383 |
| 78 | FGFR3 | 0.61829657 |
| 79 | CSF1R | 0.61312805 |
| 80 | CAMK1D | 0.61220254 |
| 81 | IKBKE | 0.59809980 |
| 82 | PRKD2 | 0.59488839 |
| 83 | TESK1 | 0.59136231 |
| 84 | MAPK7 | 0.58514283 |
| 85 | RIPK1 | 0.57913899 |
| 86 | TGFBR2 | 0.57359660 |
| 87 | PTK2 | 0.56976162 |
| 88 | PRKCQ | 0.54506954 |
| 89 | CSNK1G1 | 0.53806308 |
| 90 | TAOK1 | 0.53752599 |
| 91 | MAP3K13 | 0.51458666 |
| 92 | KIT | 0.50903218 |
| 93 | RPS6KA6 | 0.50367596 |
| 94 | RPS6KC1 | 0.50326001 |
| 95 | RPS6KL1 | 0.50326001 |
| 96 | PDPK1 | 0.50155127 |
| 97 | TTN | 0.48061897 |
| 98 | LMTK2 | 0.47130124 |
| 99 | GRK1 | 0.46937597 |
| 100 | MAP4K2 | 0.46883487 |
| 101 | SYK | 0.46529324 |
| 102 | SGK2 | 0.45331087 |
| 103 | EPHA4 | 0.44907770 |
| 104 | IGF1R | 0.44540003 |
| 105 | KSR2 | 0.43960604 |
| 106 | LCK | 0.43240008 |
| 107 | HIPK2 | 0.42898280 |
| 108 | CDK4 | 0.42114701 |
| 109 | TAOK2 | 0.42022747 |
| 110 | HCK | 0.41637366 |
| 111 | MAPK3 | 0.41327794 |
| 112 | PKN1 | 0.41185236 |
| 113 | PIK3CA | 0.41145619 |
| 114 | RET | 0.40081766 |
| 115 | BTK | 0.39763475 |
| 116 | PRKCG | 0.39377824 |
| 117 | MAP3K5 | 0.39165899 |
| 118 | MAP2K1 | 0.39120557 |
| 119 | MELK | 0.38521129 |
| 120 | JAK3 | 0.37994354 |
| 121 | ICK | 0.37587056 |
| 122 | IRAK4 | 0.37179107 |
| 123 | RPS6KA1 | 0.36288172 |
| 124 | PBK | 0.35923511 |
| 125 | MTOR | 0.34712300 |
| 126 | MAPK1 | 0.34558542 |
| 127 | CSNK1G2 | 0.34043683 |
| 128 | EGFR | 0.33951228 |
| 129 | PRKG2 | 0.33633258 |
| 130 | CSNK1G3 | 0.32251278 |
| 131 | PDK1 | 0.31405477 |
| 132 | CAMK4 | 0.31302885 |
| 133 | SGK223 | 0.30127870 |
| 134 | SGK494 | 0.30127870 |
| 135 | MAP3K6 | 0.30096112 |
| 136 | MAP3K1 | 0.28379972 |
| 137 | IRAK1 | 0.25400686 |
| 138 | PRKCA | 0.25288671 |
| 139 | LATS2 | 0.23864632 |
| 140 | IRAK2 | 0.23518783 |
| 141 | CSNK1A1L | 0.22812574 |
| 142 | ABL1 | 0.20790145 |
| 143 | MAP2K2 | 0.20466587 |
| 144 | BMX | 0.19086359 |
| 145 | CAMK1G | 0.18889943 |
| 146 | ITK | 0.18767906 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.56916845 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.68033716 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.43646944 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.34393985 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.14439277 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.78256216 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.69340857 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.65738666 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.63849465 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.59003162 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.47177191 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.37227611 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.24193091 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.12730170 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.12199147 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.08018837 |
| 17 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.94736322 |
| 18 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.91873663 |
| 19 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.91405276 |
| 20 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.90709490 |
| 21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.84794003 |
| 22 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.78813922 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.77581981 |
| 24 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.77554756 |
| 25 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.76822221 |
| 26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.75605250 |
| 27 | * Histidine metabolism_Homo sapiens_hsa00340 | 1.70426688 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.70387724 |
| 29 | Retinol metabolism_Homo sapiens_hsa00830 | 1.69530520 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.65982177 |
| 31 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.61331340 |
| 32 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.58654926 |
| 33 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.57941329 |
| 34 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.52365039 |
| 35 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.51397709 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.48699171 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.46666199 |
| 38 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.36611767 |
| 39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.35980245 |
| 40 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.34539873 |
| 41 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.31648286 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.26586846 |
| 43 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.22532282 |
| 44 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.22520288 |
| 45 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.21461005 |
| 46 | ABC transporters_Homo sapiens_hsa02010 | 1.20527924 |
| 47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.14511352 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.12074739 |
| 49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.06378626 |
| 50 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.98917811 |
| 51 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.97469010 |
| 52 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.96931281 |
| 53 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.96083334 |
| 54 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.95052830 |
| 55 | Sulfur relay system_Homo sapiens_hsa04122 | 0.94643019 |
| 56 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.86955683 |
| 57 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.84493220 |
| 58 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.84237358 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.80586289 |
| 60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.79070413 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.68934433 |
| 62 | Other glycan degradation_Homo sapiens_hsa00511 | 0.68357666 |
| 63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.65077928 |
| 64 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.64412828 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.56534913 |
| 66 | Pertussis_Homo sapiens_hsa05133 | 0.54824348 |
| 67 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.52203355 |
| 68 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.45694608 |
| 69 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.45413294 |
| 70 | Prion diseases_Homo sapiens_hsa05020 | 0.36503479 |
| 71 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.35405850 |
| 72 | Galactose metabolism_Homo sapiens_hsa00052 | 0.24845696 |
| 73 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.24238755 |
| 74 | Insulin resistance_Homo sapiens_hsa04931 | 0.22646712 |
| 75 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21665670 |
| 76 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.21348611 |
| 77 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.20938027 |
| 78 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.18154156 |
| 79 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.15389851 |
| 80 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.09441067 |
| 81 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01097425 |
| 82 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2485648 |
| 83 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2434777 |
| 84 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2359752 |
| 85 | Amoebiasis_Homo sapiens_hsa05146 | -0.2358883 |
| 86 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2310141 |
| 87 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2070036 |
| 88 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.2038277 |
| 89 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1992370 |
| 90 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1980351 |
| 91 | Hepatitis C_Homo sapiens_hsa05160 | -0.1788142 |
| 92 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1739380 |
| 93 | Influenza A_Homo sapiens_hsa05164 | -0.1708719 |
| 94 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1681824 |
| 95 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.1633615 |
| 96 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1612303 |
| 97 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.1571514 |
| 98 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1546298 |
| 99 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | -0.1530574 |
| 100 | Mineral absorption_Homo sapiens_hsa04978 | -0.1509315 |
| 101 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1411278 |
| 102 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1381814 |
| 103 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1372792 |
| 104 | Acute myeloid leukemia_Homo sapiens_hsa05221 | -0.1111456 |
| 105 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1052667 |
| 106 | Platelet activation_Homo sapiens_hsa04611 | -0.0999987 |
| 107 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0918333 |
| 108 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0886829 |
| 109 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0711087 |
| 110 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.0604445 |
| 111 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | -0.0550265 |
| 112 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0476669 |
| 113 | Pancreatic secretion_Homo sapiens_hsa04972 | -0.0436540 |
| 114 | Lysosome_Homo sapiens_hsa04142 | -0.0380332 |

